Hualan Biological EngineeringInc (002007) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Hualan Biological Engineering Inc., together with its subsidiaries, engages in the research, development, production, and sale of biological products in China and internationally.

Total Revenue Chart for Hualan Biological EngineeringInc

Hualan Biological EngineeringInc (002007) revenue for FY2025 was CNY 4.6B, a 4.5% change from FY2024. Hualan Biological EngineeringInc's revenue grew from CNY 124.4M in 2001 to CNY 4.6B in 2025 (3579.3% over 24 years). Earnings per share grew from CNY 0.01 in 2001 to CNY 0.71 in 2021 (8280.5%). Revenue compound annual growth rate: 5-year CAGR of -1.8%, 10-year CAGR of 12.0%, 20-year CAGR of 13.5%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.